Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 9/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.34 |
| ▸ | GLP1R | P43220 | 2/20 | 0.34 |
| ▸ | LOX | P28300 | 1/20 | 0.33 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | KDM1B | Q8NB78 | 2/20 | 0.33 |
| ▸ | AXL | P30530 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.32 |
| ▸ | MERTK | Q12866 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31207479 | 0.84 | SCN9A (0.45) | FFAR4SCN9AGLP1R | |
| SCHEMBL31207461 | 0.81 | ACACB (0.36) | FFAR4SCN9AKDM1AKDM1B | |
| SCHEMBL31207456 | 0.81 | RXRA (0.40) | KDM1AKDM1B | |
| SCHEMBL31207369 | 0.81 | SCN9A (0.46) | FFAR4SCN9AGLP1R | |
| SCHEMBL31207450 | 0.79 | HDAC6 (0.37) | FFAR4SCN9AGLP1R | |
| SCHEMBL15536664 | 0.74 | SCN9A (0.54) | SCN9AKDM1AKDM1B | |
| SCHEMBL31207421 | 0.71 | NR4A2 (0.40) | FFAR4SCN9A | |
| SCHEMBL31207401 | 0.70 | GRM5 (0.38) | — | |
| SCHEMBL26971185 | 0.67 | HTR7 (0.41) | SCN9AGLP1R | |
| SCHEMBL30232727 | 0.66 | GLP1R (0.50) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702021-A1 | COMPOUNDS CAPABLE OF MODULATING GPR65 | Pathios Therapeutics Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224064-A1 | COMPOUNDS CAPABLE OF MODULATING GPR65 | Pathios Therapeutics Limited (GB) | 2024-10-31 | — | — | WO | disclosed |